Key Takeaways
- • Investor consortium led by Amethis, Proparco, and ccap.ai completes acquisition of Vertice MedTech, a leading independent distributor of specialized medical devices in Southern Africa, with support from management and existing stakeholder Ethos Private Equity.
- • Vertice operates as a dual-business model: Vertice Healthcare distributes advanced medical devices (cardiovascular, orthopedics, spine, urology) through exclusive agreements with manufacturers including Abbott, Stryker, and Haemonetics; Vertice Software develops AI-driven digital health solutions delivered via SaaS platform.
- • Company has scaled significantly since 2018 founding, now employing 780+ staff across distribution centers in Pretoria, Durban, and Cape Town, with regional operations in Port Elizabeth, George, and Bloemfontein, enabling over 7,000 surgeries monthly across Sub-Saharan Africa.
- • Strategic investment targets healthcare access expansion across the continent through integrated operating model combining medical equipment distribution, clinician training via EDOnline platform, and technical support—addressing fragmented healthcare delivery in underserved markets.
- • Vertice demonstrates ESG-aligned growth with 450+ youth employment opportunities, BBBEE Level 4 certification, and digital transformation of manual health systems, positioning the platform as both a commercial and development-impact vehicle in emerging African healthcare infrastructure.
Summary
Amethis, Proparco, and ccap.ai have completed an investment in Vertice MedTech Holdings, a South African medical technology and distribution platform founded in 2018 through collaboration between Amayeza Abantu and Ethos Private Equity. The investor consortium's backing supports the management team—led by Group CEO Hendri Pretorius—to accelerate the company's next phase of growth across Southern and Sub-Saharan Africa.
Vertice operates a dual-tier business model designed to capture both distribution economics and software-enabled recurring revenue. The Vertice Healthcare division functions as the leading independent distributor of specialized medical devices, maintaining exclusive distribution agreements with over 100 international manufacturers including Abbott, Stryker, and Haemonetics. The company covers key therapeutic segments including cardiovascular, orthopedics, spine, and urology. Vertice Software develops digital health solutions—including the EDOnline training platform and AI-driven diagnostic tools—delivered through a globally scalable SaaS architecture. This integrated approach ensures that distributed medical equipment is accompanied by clinician training, installation support, and ongoing technical services, addressing a critical gap in healthcare adoption across under-resourced markets.
The company has achieved substantial scale with 780+ employees operating across three primary distribution centers (Pretoria, Durban, Cape Town) and regional hubs in Port Elizabeth, George, and Bloemfontein. Vertice enables over 7,000 surgical procedures monthly and now comprises nearly 20 specialized divisions following strategic acquisitions including LTE Medical, Amayeza Spine, Haemotec, and others. Each acquired entity maintains operational autonomy while leveraging shared support infrastructure and systems.
Beyond commercial metrics, Vertice demonstrates impact-aligned operations: the company has created over 450 employment opportunities for youth, maintains BBBEE Level 4 certification reflecting workplace empowerment commitments, and prioritizes digital transformation of paper-based health systems. The platform's tele-health and mobile screening services extend access to underserved communities. The investor consortium's backing positions Vertice to expand this integrated healthcare delivery model—combining equipment, training, software, and support—across a fragmented Sub-Saharan African healthcare landscape where sustainable implementation of medical technology remains underdeveloped.
Vertice operates a dual-tier business model designed to capture both distribution economics and software-enabled recurring revenue. The Vertice Healthcare division functions as the leading independent distributor of specialized medical devices, maintaining exclusive distribution agreements with over 100 international manufacturers including Abbott, Stryker, and Haemonetics. The company covers key therapeutic segments including cardiovascular, orthopedics, spine, and urology. Vertice Software develops digital health solutions—including the EDOnline training platform and AI-driven diagnostic tools—delivered through a globally scalable SaaS architecture. This integrated approach ensures that distributed medical equipment is accompanied by clinician training, installation support, and ongoing technical services, addressing a critical gap in healthcare adoption across under-resourced markets.
The company has achieved substantial scale with 780+ employees operating across three primary distribution centers (Pretoria, Durban, Cape Town) and regional hubs in Port Elizabeth, George, and Bloemfontein. Vertice enables over 7,000 surgical procedures monthly and now comprises nearly 20 specialized divisions following strategic acquisitions including LTE Medical, Amayeza Spine, Haemotec, and others. Each acquired entity maintains operational autonomy while leveraging shared support infrastructure and systems.
Beyond commercial metrics, Vertice demonstrates impact-aligned operations: the company has created over 450 employment opportunities for youth, maintains BBBEE Level 4 certification reflecting workplace empowerment commitments, and prioritizes digital transformation of paper-based health systems. The platform's tele-health and mobile screening services extend access to underserved communities. The investor consortium's backing positions Vertice to expand this integrated healthcare delivery model—combining equipment, training, software, and support—across a fragmented Sub-Saharan African healthcare landscape where sustainable implementation of medical technology remains underdeveloped.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.